<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40670172</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0255-2930</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion</Title><ISOAbbreviation>Zhongguo Zhen Jiu</ISOAbbreviation></Journal><ArticleTitle>[Effect of moxibustion on small intestinal mucosal immune barrier in rats with diarrhea-predominant irritable bowel syndrome].</ArticleTitle><Pagination><StartPage>935</StartPage><EndPage>944</EndPage><MedlinePgn>935-944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.13703/j.0255-2930.20231216-k0002</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To observe the effect of moxibustion on small intestinal mucosal immune barrier in rats with diarrhea-predominant irritable bowel syndrome (IBS-D) and explore its underlying mechanisms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Of 38 newborn rats from 4 healthy SPF pregnant rats, 12 neonatal rats were randomly selected in a normal group. IBS-D model was prepared by the combined measures for the rest rats, including neonatal maternal separation, acetic acid enema and chronic restraint stress. Twenty-four successfully-modeled rats were randomized into a model group and a moxibustion group, 12 rats in each one. In the moxibustion group, suspending moxibustion was delivered at bilateral "Tianshu" (ST25) and "Shangjuxu" (ST37), 20 min each time, once daily and for 7 consecutive days. Separately, before acetic acid enema (aged 35 days), after modeling (aged 45 days) and after intervention (aged 53 days), the body mass, loose stool rate (LSR) and and the minimum volume threshold when abdominal withdrawal reflex (AWR) scored 3 were observed in the rats of each group. After intervention (aged 53 days), using HE and PAS staining, the morphology of duodenum was observed, the length of villus and the depth of crypt were measured, the ratio of the length of villus to the depth of crypt was calculated; and the numbers of mucosal intraepithelial lymphocytes (IELs) and goblet cells were counted. With ELISA adopted, the contents of &#x3b3;-interferon (IFN-&#x3b3;), interleukin-4 (IL-4) and secretory immunoglobulin A (sIgA) in duodenal mucosa of rats were detected. The proportion of T cell subsets in duodenal mucosa was detected using flow cytometry. The microvilli and tight junctions of duodenal mucosal epithelial cells were observed by transmission electron microscopy, and the integrity of duodenal mucosa observed by scanning electron microscopy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Compared with the normal group, for the rats in the model group, the body mass, the minimum volume threshold when AWR scored 3, the length of duodenal villus and the the ratio of the length of villus to the depth of crypt, as well as the proportion of CD<sub>8</sub><sup>+</sup> T subset were all reduced (<i>P</i>&lt;0.01, <i>P</i>&lt;0.05), the counts of goblet cells in duodenal mucosa decreased (<i>P</i>&lt;0.01); LRS, the proportion of CD<sub>4</sub><sup>+</sup> T subset and CD<sub>4</sub><sup>+</sup>/CD<sub>8</sub><sup>+</sup>, as well as the contents of IFN-&#x3b3;, IL-4 and sIgA in duodenal mucosa and IFN-&#x3b3;/IL-4 were all elevated (<i>P</i>&lt;0.01); and the numbers of IELs rose (<i>P</i>&lt;0.01). The morphology of duodenal mucosa was irregular, the villi got shorter, sparse and scattered, with uneven density. The morphology of epithelial cells was destroyed and the tight junctions damaged, with larger spaces. When compared with the model group, in the moxibustion group, the body mass, the minimum volume threshold when AWR scored 3, the length of duodenal villus and the ratio of the length of villus to the depth of crypt, as well as the counts of goblet cells in duodenal mucosa increased (<i>P</i>&lt;0.01); LRS, the proportion of CD<sub>4</sub><sup>+</sup> T subset, and CD<sub>4</sub><sup>+</sup>/CD<sub>8</sub><sup>+</sup>, as well as the contents of IFN-&#x3b3;, IL-4 and sIgA in duodenal mucosa and IFN-&#x3b3;/IL-4 were reduced (<i>P</i>&lt;0.01); and the numbers of IELs was dropped (<i>P</i>&lt;0.01). The morphology of duodenal mucosa was more regular, the villi were grew, got longer and arranged regularly, with even density. The morphology of epithelial cells was slightly destroyed, and the tight junctions partially damaged.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Moxibustion at "Tianshu" (ST25) and "Shangjuxu" (ST37) can reduce visceral hypersensitivity in IBS-D rats and relieve abdominal pain, diarrhea and other symptoms. Its effect mechanism may be related to the repair of small intestinal mucosal immune barrier and the improvement in the immune function in IBS-D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kuiwu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Second Affiliated Hospital of Anhui University of CM/Anhui Provincial Acupuncture Hospital, Hefei 230061; Clinical Research Institute of Acupuncture and Moxibustion, Anhui Academy of TCM, Hefei 230061; Anhui Clinical Medical Research Center of Acupuncture and Moxibustion, Hefei 230061; Institute of Xin'an Medicine and Modernization of TCM, Anhui University of CM, Hefei 230012.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Jingru</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Lumin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Wenli</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jingwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yucheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ziye</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Second Clinical Medical College, Anhui University of CM, Hefei 230061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Second Affiliated Hospital of Anhui University of CM/Anhui Provincial Acupuncture Hospital, Hefei 230061.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhongguo Zhen Jiu</MedlineTA><NlmUniqueID>8600658</NlmUniqueID><ISSNLinking>0255-2930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009071" MajorTopicYN="Y">Moxibustion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="Y">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="Y">Diarrhea</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="Y">Intestine, Small</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b>&#x89c2;&#x5bdf;&#x827e;&#x7078;&#x5bf9;&#x8179;&#x6cfb;&#x578b;&#x80a0;&#x6613;&#x6fc0;&#x7efc;&#x5408;&#x5f81;&#xff08;IBS-D&#xff09;&#x6a21;&#x578b;&#x5927;&#x9f20;&#x5c0f;&#x80a0;&#x9ecf;&#x819c;&#x514d;&#x75ab;&#x5c4f;&#x969c;&#x7684;&#x5f71;&#x54cd;&#xff0c;&#x63a2;&#x8ba8;&#x827e;&#x7078;&#x5e72;&#x9884;IBS-D&#x7684;&#x53ef;&#x80fd;&#x4f5c;&#x7528;&#x673a;&#x5236;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b>&#x4ece;4&#x53ea;&#x5065;&#x5eb7;SPF&#x7ea7;&#x5b55;&#x9f20;&#x4ea7;&#x4e0b;&#x7684;38&#x53ea;&#x5e7c;&#x9f20;&#x4e2d;&#x968f;&#x673a;&#x9009;&#x53d6;12&#x53ea;&#x4e3a;&#x6b63;&#x5e38;&#x7ec4;&#xff0c;&#x5269;&#x4f59;&#x5927;&#x9f20;&#x91c7;&#x7528;&#x4e09;&#x56e0;&#x7d20;&#x8054;&#x5408;&#x6cd5;&#x5236;&#x5907;IBS-D&#x6a21;&#x578b;&#xff0c;&#x5c06;&#x9020;&#x6a21;&#x6210;&#x529f;&#x7684;24&#x53ea;&#x5927;&#x9f20;&#x968f;&#x673a;&#x5206;&#x4e3a;&#x6a21;&#x578b;&#x7ec4;&#x3001;&#x827e;&#x7078;&#x7ec4;&#xff0c;&#x6bcf;&#x7ec4;12&#x53ea;&#x3002;&#x827e;&#x7078;&#x7ec4;&#x4e8e;&#x53cc;&#x4fa7;&#x201c;&#x5929;&#x67a2;&#x201d;&#x201c;&#x4e0a;&#x5de8;&#x865a;&#x201d;&#x884c;&#x60ac;&#x7078;&#x5e72;&#x9884;&#xff0c;&#x6bcf;&#x5929;1&#x6b21;&#xff0c;&#x6bcf;&#x6b21;20 min&#xff0c;&#x8fde;&#x7eed;7 d&#x3002;&#x5206;&#x522b;&#x4e8e;&#x918b;&#x9178;&#x704c;&#x80a0;&#x524d;&#xff08;35&#x65e5;&#x9f84;&#xff09;&#x3001;&#x9020;&#x6a21;&#x540e;&#xff08;45&#x65e5;&#x9f84;&#xff09;&#x3001;&#x5e72;&#x9884;&#x540e;&#xff08;53&#x65e5;&#x9f84;&#xff09;&#x89c2;&#x5bdf;&#x5404;&#x7ec4;&#x5927;&#x9f20;&#x4f53;&#x8d28;&#x91cf;&#x3001;&#x7a00;&#x4fbf;&#x7387;&#xff08;LSR&#xff09;&#x3001;&#x5f15;&#x8d77;&#x8179;&#x90e8;&#x56de;&#x7f29;&#x53cd;&#x5c04;&#xff08;AWR&#xff09;&#x8bc4;&#x5206;3&#x5206;&#x65f6;&#x6700;&#x5c0f;&#x5bb9;&#x91cf;&#x9608;&#x503c;&#x3002;&#x5e72;&#x9884;&#x540e;&#xff08;53&#x65e5;&#x9f84;&#xff09;&#xff0c;&#x91c7;&#x7528;HE&#x548c;PAS&#x67d3;&#x8272;&#x6cd5;&#x89c2;&#x5bdf;&#x5927;&#x9f20;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x7ec4;&#x7ec7;&#x5f62;&#x6001;&#xff0c;&#x6d4b;&#x91cf;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x7ed2;&#x6bdb;&#x957f;&#x5ea6;&#x4e0e;&#x9690;&#x7a9d;&#x6df1;&#x5ea6;&#xff0c;&#x8ba1;&#x7b97;&#x7ed2;&#x817a;&#x6bd4;&#xff08;&#x7ed2;&#x6bdb;&#x957f;&#x5ea6;/&#x9690;&#x7a9d;&#x6df1;&#x5ea6;&#xff09;&#xff0c;&#x7edf;&#x8ba1;&#x9ecf;&#x819c;&#x4e0a;&#x76ae;&#x5185;&#x6dcb;&#x5df4;&#x7ec6;&#x80de;&#xff08;IELs&#xff09;&#x548c;&#x676f;&#x72b6;&#x7ec6;&#x80de;&#x6570;&#x91cf;&#xff1b;ELISA&#x6cd5;&#x68c0;&#x6d4b;&#x5927;&#x9f20;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x7ec4;&#x7ec7;&#x3b3;-&#x5e72;&#x6270;&#x7d20;&#xff08;IFN-&#x3b3;&#xff09;&#x3001;&#x767d;&#x4ecb;&#x7d20;-4&#xff08;IL-4&#xff09;&#x548c;&#x5206;&#x6ccc;&#x578b;&#x514d;&#x75ab;&#x7403;&#x86cb;&#x767d;A&#xff08;sIgA&#xff09;&#x542b;&#x91cf;&#xff1b;&#x6d41;&#x5f0f;&#x7ec6;&#x80de;&#x672f;&#x68c0;&#x6d4b;&#x5927;&#x9f20;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;T&#x7ec6;&#x80de;&#x4e9a;&#x7fa4;&#x6bd4;&#x4f8b;&#xff1b;&#x900f;&#x5c04;&#x7535;&#x955c;&#x89c2;&#x5bdf;&#x5927;&#x9f20;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x4e0a;&#x76ae;&#x7ec6;&#x80de;&#x5fae;&#x7ed2;&#x6bdb;&#x548c;&#x7d27;&#x5bc6;&#x8fde;&#x63a5;&#xff1b;&#x626b;&#x63cf;&#x7535;&#x955c;&#x89c2;&#x5bdf;&#x5927;&#x9f20;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x5b8c;&#x6574;&#x6027;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b>&#x4e0e;&#x6b63;&#x5e38;&#x7ec4;&#x6bd4;&#x8f83;&#xff0c;&#x6a21;&#x578b;&#x7ec4;&#x5927;&#x9f20;&#x4f53;&#x8d28;&#x91cf;&#x3001;AWR&#x8bc4;&#x5206;3&#x5206;&#x65f6;&#x6700;&#x5c0f;&#x5bb9;&#x91cf;&#x9608;&#x503c;&#x3001;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x7ed2;&#x6bdb;&#x957f;&#x5ea6;&#x53ca;&#x7ed2;&#x817a;&#x6bd4;&#x3001;CD<sub>8</sub><sup>+</sup> T&#x7ec6;&#x80de;&#x6bd4;&#x4f8b;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.01&#xff0c;<i>P</i>&lt;0.05&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x676f;&#x72b6;&#x7ec6;&#x80de;&#x6570;&#x91cf;&#x51cf;&#x5c11;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff1b;LSR&#x3001;CD<sub>4</sub><sup>+</sup> T&#x7ec6;&#x80de;&#x6bd4;&#x4f8b;&#x3001;CD<sub>4</sub><sup>+</sup>/CD<sub>8</sub><sup>+</sup>&#x503c;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x80a0;&#x9ecf;&#x819c;IFN-&#x3b3;&#x3001;IL-4&#x3001;sIgA&#x542b;&#x91cf;&#x53ca;IFN-&#x3b3;/IL-4&#x503c;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;IELs&#x6570;&#x91cf;&#x589e;&#x591a;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff1b;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x5f62;&#x6001;&#x6b20;&#x89c4;&#x6574;&#xff0c;&#x7ed2;&#x6bdb;&#x53d8;&#x77ed;&#x3001;&#x7a00;&#x758f;&#x6563;&#x4e71;&#xff0c;&#x5bc6;&#x5ea6;&#x4e0d;&#x5747;&#xff0c;&#x4e0a;&#x76ae;&#x7ec6;&#x80de;&#x5f62;&#x6001;&#x7834;&#x574f;&#xff0c;&#x7d27;&#x5bc6;&#x8fde;&#x63a5;&#x53d7;&#x635f;&#xff0c;&#x95f4;&#x9699;&#x589e;&#x5bbd;&#x3002;&#x4e0e;&#x6a21;&#x578b;&#x7ec4;&#x6bd4;&#x8f83;&#xff0c;&#x827e;&#x7078;&#x7ec4;&#x5927;&#x9f20;&#x4f53;&#x8d28;&#x91cf;&#x3001;AWR&#x8bc4;&#x5206;3&#x5206;&#x65f6;&#x6700;&#x5c0f;&#x5bb9;&#x91cf;&#x9608;&#x503c;&#x3001;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x7ed2;&#x6bdb;&#x957f;&#x5ea6;&#x53ca;&#x7ed2;&#x817a;&#x6bd4;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;&#x676f;&#x72b6;&#x7ec6;&#x80de;&#x6570;&#x91cf;&#x589e;&#x591a;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff1b;LSR&#x3001;CD<sub>4</sub><sup>+</sup> T&#x7ec6;&#x80de;&#x6bd4;&#x4f8b;&#x3001;CD<sub>4</sub><sup>+</sup>/CD<sub>8</sub><sup>+</sup>&#x503c;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x80a0;&#x9ecf;&#x819c;IFN-&#x3b3;&#x3001;IL-4&#x3001;sIgA&#x542b;&#x91cf;&#x53ca;IFN-&#x3b3;/IL-4&#x503c;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x9ecf;&#x819c;IELs&#x6570;&#x91cf;&#x51cf;&#x5c11;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff1b;&#x5341;&#x4e8c;&#x6307;&#x80a0;&#x80a0;&#x9ecf;&#x819c;&#x8f83;&#x89c4;&#x6574;&#xff0c;&#x7ed2;&#x6bdb;&#x589e;&#x591a;&#x53d8;&#x957f;&#xff0c;&#x6392;&#x5217;&#x6574;&#x9f50;&#xff0c;&#x5bc6;&#x5ea6;&#x8f83;&#x5747;&#x5300;&#xff0c;&#x4e0a;&#x76ae;&#x7ec6;&#x80de;&#x5f62;&#x6001;&#x7565;&#x6709;&#x7834;&#x574f;&#xff0c;&#x7d27;&#x5bc6;&#x8fde;&#x63a5;&#x90e8;&#x5206;&#x53d7;&#x635f;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b>&#x827e;&#x7078;&#x201c;&#x5929;&#x67a2;&#x201d;&#x201c;&#x4e0a;&#x5de8;&#x865a;&#x201d;&#x53ef;&#x964d;&#x4f4e;IBS-D&#x6a21;&#x578b;&#x5927;&#x9f20;&#x5185;&#x810f;&#x9ad8;&#x654f;&#x611f;&#x6027;&#xff0c;&#x51cf;&#x8f7b;&#x8179;&#x75db;&#x53ca;&#x8179;&#x6cfb;&#x7b49;&#x75c7;&#x72b6;&#xff0c;&#x5176;&#x4f5c;&#x7528;&#x673a;&#x5236;&#x53ef;&#x80fd;&#x4e0e;&#x4fee;&#x590d;&#x5c0f;&#x80a0;&#x9ecf;&#x819c;&#x514d;&#x75ab;&#x5c4f;&#x969c;&#xff0c;&#x6539;&#x5584;IBS-D&#x514d;&#x75ab;&#x529f;&#x80fd;&#x72b6;&#x6001;&#x6709;&#x5173;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diarrhea-predominant irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">duodenum</Keyword><Keyword MajorTopicYN="N">immune function</Keyword><Keyword MajorTopicYN="N">moxibustion</Keyword><Keyword MajorTopicYN="N">mucosal immune barrier</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40670172</ArticleId><ArticleId IdType="doi">10.13703/j.0255-2930.20231216-k0002</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>